Hait Bioscience (300683.SZ) released its first half year performance, with a net loss of 39.1799 million yuan attributable to the parent company, an increase of 72.10%.

Zhtng Cijng APP xn, hi t shngw (300683.SZ) fb 2025 nin bnnin d bogo, gi gngs yngy shur wi 2.75 y yun, tngb jinsho 3.36%. Gush y shngsh gngs gdng de jng kusn wi 3917.99 wn yun, tngb kud 72.10%. Gush y shngsh gngs gdng de kuch fi jngchngxng sny de jng kusn wi 5747.59 wn yun, tngb kud 22.19%. Jbn mi g kusn wi 0.3 yun. Zhtng Cijng APP News, Haite Biological (300683.SZ) released its 2025 interim report, with the company's operating income at 275 million yuan, a decrease of 3.36% year-on-year. The net loss attributable to shareholders of the listed company was 39.1799 million yuan, an increase of 72.10% year-on-year. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 57.4759 million yuan, an increase of 22.19% year-on-year. Basic loss per share was 0.3 yuan.